Kangxinuo was established in Tianjin, China on June 5438+1October 65438+March, 2009, and is committed to the research, development, production and commercialization of innovative vaccines for public health in China and around the world. Is a Sino-foreign joint venture, the foreign investor is British, as long as it provides research support to Conceino.
Its business scope includes: research and development, technology transfer, production and technical consulting services of chemicals, biopharmaceuticals, vaccines and diagnostic reagents. Wholesale, import and export of chemicals, biological products and consumables.